Privia Health
PRVA
280 hedge funds and large institutions have $2.57B invested in Privia Health in 2025 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 108 increasing their positions, 89 reducing their positions, and 19 closing their positions.
434% more call options, than puts
Call options by funds: $5.48M | Put options by funds: $1.03M
179% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 19
21% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 89
13% more funds holding
Funds holding: 248 → 280 (+32)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $2.58B → $2.57B (-$6.32M)
3.57% less ownership
Funds ownership: 95.33% → 91.77% (-3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
+$20.6M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$15.6M |
| 3 |
FGP
Freestone Grove Partners
San Francisco,
California
|
+$12.5M |
| 4 |
BlackRock
New York
|
+$11.1M |
| 5 |
Millennium Management
New York
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$92.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$31.3M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$13.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$12.1M |
PRVA Hedge Fund Activity: Q2 2025 in Review
280 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q2 2025, worth a combined $2.57B — down 0.25% from $2.58B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new PRVA positions and 19 closed out — a net gain of 34 holders — while 108 added to existing stakes and 89 trimmed.
The largest buyer was Van Berkom & Associates, adding an estimated $20.6M. The largest seller was Fidelity Investments, cutting an estimated $92.2M.
- 280 institutional investors held Privia Health (PRVA) as of Q2 2025, up from 248 in Q1 2025.
- Funds reported $2.57B of Privia Health stock for Q2 2025, down 0.25% quarter-over-quarter.
- 53 funds opened new Privia Health positions in Q2 2025 and 19 closed out, a net change of +34 holders.
- The largest Privia Health buyer in Q2 2025 was Van Berkom & Associates, an estimated $20.6M added.
- The largest Privia Health seller in Q2 2025 was Fidelity Investments, an estimated $92.2M sold.
Based on aggregated 13F filings for Q2 2025.